Market Overview

Benzinga's Top #PreMarket Gainers

Share:
Related PCBK
Pacific Continental Upgraded By Raymond James, Sets $18 Price Target
Raymond James Downgrades Six Banking Stocks
Related ZBRA
Vetr Crowd Says Zebra Technologies Could Return More Than 25%
Goldman Highlights Zebra As 'An Industry Leader' Within A 'Market In Transition'
The Vetr community has downgraded $ZBRA to 2.5-Stars (Vetr)

Pacific Continental (NASDAQ: PCBK) shares gained 18.42% to $15.75 in the pre-market after dropping 1.55% on Monday. Pacific Continental is expected to report its Q1 earnings on April 17, 2014.

Zebra Technologies (NASDAQ: ZBRA) shares gained 9.80% to $74.97 in the pre-market trading session after the company announced its plans to buy Motorola's enterprise business from Motorola Solutions (NYSE: MSI) for $3.45 billion. Zebra Tech also issued upbeat Q1 earnings forecast.

Halozyme Therapeutics (NASDAQ: HALO) surged 9.60% to $7.88 in pre-market trading. Citigroup initiated coverage on Halozyme Therapeuticswith a Buy rating and a $12.00 price target.

Morgan Stanley (NYSE: MS) shares jumped 4.50% to $29.75 in pre-market trading. Bank of America upgraded Morgan Stanley from Neutral to Buy.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (HALO + MS)

View Comments and Join the Discussion!